An investigational blood-based test identified nearly 80% of individuals who had colorectal cancer, according to results of a ...

The Galleri test — which isn’t covered by insurance — doesn’t come cheap. At $949 a pop, it’s out of the price range of most ...

The Galleri test, developed by Grail, screens for over 50 types of cancer with a single blood draw. Despite its potential ...

A novel blood-based test for early detection of colorectal cancer in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC trial.

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...

Scientists at the University of Exeter have found a new way of interpreting standard blood tests to help GPs spot cancer ...

The test employs a combination of tumour-agnostic next-generation sequencing and personalised tumour-informed droplet PCR ...

Despite the availability of several noninvasive tests for colorectal cancer, prioritizing blood-based tests may result in ...

According to the Centers for Disease Control and Prevention ( CDC ), ovarian cancer may cause vaginal bleeding, pelvic pain, ...

The Galleri test, developed by Grail, screens for over 50 types of cancer with a single blood draw. Despite its potential benefits, including identifying cancers early, it faces criticism for lack ...

Datar Cancer Genetics (DCG) today announced the launch of Target-MRD, an advanced molecular residual disease (MRD) monitoring ...